Literature DB >> 22257914

[Guidelines on prevention and treatment of vitamin D deficiency. Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)].

S Adami1, E Romagnoli, V Carnevale, A Scillitani, A Giusti, M Rossini, D Gatti, R Nuti, S Minisola.   

Abstract

The Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) has elaborated the following guidelines about the definition, prevention and treatment of inadequate vitamin D status. The highlights are presented here. Daily vitamin D allowance ranges from 1,500 IU (healthy adults) to 2,300 IU (elderly with low calcium intake). Since the average Italian diet includes around 300 IU/day, subjects with no effective sun exposure should be supplemented with 1,200-2,000 IU vitamin D per day. The serum 25-hydroxy-vitamin D [25(OH)D] levels represents the most accurate way to assess vitamin D repletion, even though there are still no standardized assay methods. Conditions of “deficiency” and “insufficiency” are defined by the following ranges of 25(OH)D levels: less than 20 ng/ml and 20-30 ng/ml, respectively. In Italy, approximately 50% of young healthy subjects have vitamin D insufficiency during the winter months. The prevalence of deficiency increases with ageing, affecting almost all elderly subjects not on vitamin D supplements. When a condition of deficiency has been identified, a cumulative dose of 300,000-1,000,000 IU, over 1-4 weeks is recommended. In subjects recently treated for deficiency-insufficiency, a maintenance dose of 800-2,000 IU/day (or weekly equivalent) is recommended. In patients on daily doses over 1,000 IU, 25(OH)D levels should be checked regularly (e.g. once every two years). The highest tolerated daily dose has been identified as 4,000 IU/day. Vitamin D supplementation should be carefully monitored in patients at higher risk of vitamin D intoxication (granulomatosis) or with primary hyperparathyroidism. In pregnant women, vitamin D supplements should be given as in non-pregnant women, but bolus administration (i.e.: single dose >25,000 IU) should be avoided.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22257914     DOI: 10.4081/reumatismo.2011.129

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  36 in total

1.  Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk.

Authors:  Luca Degli Esposti; Anna Girardi; Stefania Saragoni; Stefania Sella; Margherita Andretta; Maurizio Rossini; Sandro Giannini
Journal:  Endocrine       Date:  2018-12-04       Impact factor: 3.633

Review 2.  Update on vitamin D: pros and cons.

Authors:  Cristiana Cipriani; Sara Piemonte; Mirella Cilli; Jessica Pepe; Salvatore Minisola
Journal:  Clin Cases Miner Bone Metab       Date:  2015-12-29

3.  Changing patterns of prescription in vitamin D supplementation in adults: analysis of a regional dataset.

Authors:  L Cianferotti; S Parri; G Gronchi; C Rizzuti; C Fossi; D M Black; M L Brandi
Journal:  Osteoporos Int       Date:  2015-06-12       Impact factor: 4.507

Review 4.  Screening, diagnosis and treatment of osteoporosis: a brief review.

Authors:  Roberto Bernabei; Anna Maria Martone; Elena Ortolani; Francesco Landi; Emanuele Marzetti
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

5.  Dietary habits and supplement use in relation to national pregnancy recommendations: data from the EuroPrevall birth cohort.

Authors:  E M Oliver; K E C Grimshaw; A A Schoemaker; T Keil; D McBride; A B Sprikkelman; H S Ragnarsdottir; V Trendelenburg; E Emmanouil; M Reche; A Fiocchi; A Fiandor; A Stanczyk-Przyluska; J Wilczynski; M Busacca; S T Sigurdardottir; R Dubakiene; O Rudzeviciene; G D Vlaxos; K Beyer; G Roberts
Journal:  Matern Child Health J       Date:  2014-12

6.  Development of an algorithm to predict serum vitamin D levels using a simple questionnaire based on sunlight exposure.

Authors:  Edda Vignali; Enrico Macchia; Filomena Cetani; Giorgio Reggiardo; Luisella Cianferotti; Federica Saponaro; Claudio Marcocci
Journal:  Endocrine       Date:  2016-03-10       Impact factor: 3.633

Review 7.  Vitamin D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects.

Authors:  Massimiliano Caprio; Marco Infante; Matilde Calanchini; Caterina Mammi; Andrea Fabbri
Journal:  Eat Weight Disord       Date:  2016-08-23       Impact factor: 4.652

8.  Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes?

Authors:  Chiara Baldini; Andrea Delle Sedie; Nicoletta Luciano; Pasquale Pepe; Francesco Ferro; Rosaria Talarico; Chiara Tani; Marta Mosca
Journal:  Rheumatol Int       Date:  2013-10-06       Impact factor: 2.631

9.  Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners.

Authors:  F Buckinx; J Y Reginster; E Cavalier; J Petermans; C Ricour; C Dardenne; O Bruyère
Journal:  Osteoporos Int       Date:  2016-01-05       Impact factor: 4.507

10.  Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis.

Authors:  E Cairoli; C Eller-Vainicher; F M Ulivieri; V V Zhukouskaya; S Palmieri; V Morelli; P Beck-Peccoz; I Chiodini
Journal:  Osteoporos Int       Date:  2014-02-08       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.